Literature DB >> 12765951

Leptin activation of corticosterone production in hepatocytes may contribute to the reversal of obesity and hyperglycemia in leptin-deficient ob/ob mice.

Yanjun Liu1, Yuichi Nakagawa, Ying Wang, Renshan Li, Xiaojun Li, Takehiko Ohzeki, Theodore C Friedman.   

Abstract

Glucocorticoids have been implicated as pathophysiological mediators of obesity and insulin resistance and are regulated by 11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1). This enzyme regenerates active corticosterone from inactive 11-keto forms. To assess the role of 11beta-HSD1-mediated synthesis of active corticosterone in leptin-related obesity and diabetes, we examined the peripheral effect of leptin on 11beta-HSD1 activity and gene expression in vivo and in vitro in hepatocytes from ob/ob mice and in liver of streptozotocin (STZ)-treated ob/ob mice. We observed an inverse relationship between hepatic 11beta-HSD1 expression and body weight in ob/ob mice and lean littermates. Leptin treatment of ob/ob mice markedly increased hepatic 11beta-HSD1 activity and mRNA expression. This induction of 11beta-HSD1 expression corresponded to reduced levels of circulating corticosterone and weight loss in ob/ob mice treated with leptin, indicating that impaired hepatic 11beta-HSD1 expression may contribute to the pathogenesis of obesity in ob/ob mice. In addition, leptin treatment of STZ-treated ob/ob mice caused marked increases in hepatic 11beta-HSD1 levels associated with decreased body weight and a significant reduction in hyperglycemia due to pancreatic beta-cell damage. Addition of leptin to ob/ob mouse primary hepatocytes led to a dose-dependent increase in 11beta-HSD1 mRNA expression. In contrast, leptin did not influence 11beta-HSD1 expression in primary hepatocytes from db/db mice, indicating that leptin regulation of 11beta-HSD1 expression is probably mediated by the functional leptin receptor. Thus, leptin appears to be an important metabolic signal that directly activates intrahepatic corticosterone production. These findings suggest that the liver-specific interaction of leptin with 11beta-HSD1 is involved in the development of obesity and insulin resistance in ob/ob mice.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12765951     DOI: 10.2337/diabetes.52.6.1409

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  18 in total

Review 1.  Inhibition of 11beta-hydroxysteroid dehydrogenase type 1 in obesity.

Authors:  Deborah J Wake; Brian R Walker
Journal:  Endocrine       Date:  2006-02       Impact factor: 3.633

2.  G6PT-H6PDH-11βHSD1 triad in the liver and its implication in the pathomechanism of the metabolic syndrome.

Authors:  Ibolya Czegle; Miklós Csala; József Mandl; Angelo Benedetti; István Karádi; Gábor Bánhegyi
Journal:  World J Hepatol       Date:  2012-04-27

Review 3.  Leptin: at the crossroads of energy balance and systemic inflammation.

Authors:  Alexandre A Steiner; Andrej A Romanovsky
Journal:  Prog Lipid Res       Date:  2006-12-21       Impact factor: 16.195

4.  Interplay between H6PDH and 11β-HSD1 implicated in the pathogenesis of type 2 diabetes mellitus.

Authors:  Fan Yao; Li Chen; Zheng Fan; Fei Teng; Yali Zhao; Fengying Guan; Ming Zhang; Yanjun Liu
Journal:  Bioorg Med Chem Lett       Date:  2017-07-15       Impact factor: 2.823

5.  Tissue-specific dysregulation of hexose-6-phosphate dehydrogenase and glucose-6-phosphate transporter production in db/db mice as a model of type 2 diabetes.

Authors:  Y Wang; Y Nakagawa; L Liu; W Wang; X Ren; A Anghel; K Lutfy; T C Friedman; Y Liu
Journal:  Diabetologia       Date:  2010-11-04       Impact factor: 10.122

6.  Enhanced glycogen metabolism in adipose tissue decreases triglyceride mobilization.

Authors:  Kathleen R Markan; Michael J Jurczak; Margaret B Allison; Honggang Ye; Maria M Sutanto; Ronald N Cohen; Matthew J Brady
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-04-27       Impact factor: 4.310

7.  Reduction of hepatic glucocorticoid receptor and hexose-6-phosphate dehydrogenase expression ameliorates diet-induced obesity and insulin resistance in mice.

Authors:  Yanjun Liu; Yuichi Nakagawa; Ying Wang; Limei Liu; Hongwei Du; Wei Wang; Xiuhai Ren; Kabirullah Lutfy; Theodore C Friedman
Journal:  J Mol Endocrinol       Date:  2008-06-04       Impact factor: 5.098

8.  Increased whole-body and sustained liver cortisol regeneration by 11beta-hydroxysteroid dehydrogenase type 1 in obese men with type 2 diabetes provides a target for enzyme inhibition.

Authors:  Roland H Stimson; Ruth Andrew; Norma C McAvoy; Dhiraj Tripathi; Peter C Hayes; Brian R Walker
Journal:  Diabetes       Date:  2011-01-24       Impact factor: 9.461

9.  Neonatal overfeeding induced by small litter rearing causes altered glucocorticoid metabolism in rats.

Authors:  Miao Hou; Yanhua Liu; Lijun Zhu; Bin Sun; Mei Guo; Jonas Burén; Xiaonan Li
Journal:  PLoS One       Date:  2011-11-04       Impact factor: 3.240

10.  SETDB2 Links Glucocorticoid to Lipid Metabolism through Insig2a Regulation.

Authors:  Manuel Roqueta-Rivera; Ryan M Esquejo; Peter E Phelan; Katalin Sandor; Bence Daniel; Fabienne Foufelle; Jun Ding; Xiaoman Li; Sepideh Khorasanizadeh; Timothy F Osborne
Journal:  Cell Metab       Date:  2016-08-25       Impact factor: 27.287

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.